In order to investigate the downstream mechanisms accounting for the different regulatory effects of MrgD and Ala towards cardiac hypertrophy and fibrosis, we detected the expression of MrgD in the membrane, cytoplasm, and nuclear region of NRCM and NRCF. The gene discussed is MRGPRD; the disease is cardiac hypertrophy.